What is low molecular weight Heparin?
Low molecular weight heparin (LMWH) is a medication which thins the blood. It helps prevent blood clots from forming in the veins and treats blood clots already present in the veins by preventing the blood clot from extending or getting larger. LMWH is generally used for only a short period of time for anticoagulation (blood thinning), while coumadin (a blood thinner in pill form) is for longer term anticoagulation. It can be given once or twice a day by a simple injection under the skin. The patient or family member can be taught to give the injection. The use of LMWH has allowed patients with blood clots to be treated at home, or with only a short hospital stay in some cases. What are the side effects? The major side effect associated with LMWH, as with any blood thinner, is bleeding. You must notify your physician if you have any unusual bleeding, for example, heavy nosebleeds, bleeding gums, vomiting blood, blood in bowel movements, or heavy vaginal bleeding. LMWH can cause local i
- Is it possible to obtain coverage for low molecular weight heparin (LMWH) for treatment of venous thromboembolism (VTE) in cancer patients?
- What is the difference between Coamatic Heparin, Coatest Heparin, Coatest and Low Molecular Weight Heparin / Heparin?
- What are Low Molecular Weight Heparins and how do they differ from standard heparin?